Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP475349.RAZ1uRcd-VVuSeu1qLdbdqFENrx8bO6tMd638nq1NuXhg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP475349.RAZ1uRcd-VVuSeu1qLdbdqFENrx8bO6tMd638nq1NuXhg130_assertion type Assertion NP475349.RAZ1uRcd-VVuSeu1qLdbdqFENrx8bO6tMd638nq1NuXhg130_head.
- NP475349.RAZ1uRcd-VVuSeu1qLdbdqFENrx8bO6tMd638nq1NuXhg130_assertion description "[Among 90 primary gastric adenocarcinomas examined, 41 (46%) and 19 (21%) expressed no or abnormally low levels of RASSF1A and RASSF1B, respectively, and 12 (13%) tumors showed no expression of both isoforms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP475349.RAZ1uRcd-VVuSeu1qLdbdqFENrx8bO6tMd638nq1NuXhg130_provenance.
- NP475349.RAZ1uRcd-VVuSeu1qLdbdqFENrx8bO6tMd638nq1NuXhg130_assertion evidence source_evidence_literature NP475349.RAZ1uRcd-VVuSeu1qLdbdqFENrx8bO6tMd638nq1NuXhg130_provenance.
- NP475349.RAZ1uRcd-VVuSeu1qLdbdqFENrx8bO6tMd638nq1NuXhg130_assertion SIO_000772 11585730 NP475349.RAZ1uRcd-VVuSeu1qLdbdqFENrx8bO6tMd638nq1NuXhg130_provenance.
- NP475349.RAZ1uRcd-VVuSeu1qLdbdqFENrx8bO6tMd638nq1NuXhg130_assertion wasDerivedFrom befree-20140225 NP475349.RAZ1uRcd-VVuSeu1qLdbdqFENrx8bO6tMd638nq1NuXhg130_provenance.
- NP475349.RAZ1uRcd-VVuSeu1qLdbdqFENrx8bO6tMd638nq1NuXhg130_assertion wasGeneratedBy ECO_0000203 NP475349.RAZ1uRcd-VVuSeu1qLdbdqFENrx8bO6tMd638nq1NuXhg130_provenance.